© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 16, 1382-1390,
August 18, 1999
© 1999 Oxford University Press
Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality
Affiliations of authors: J. M. Legler, L. A. Gloeckler Ries, J. L. Warren (Cancer Surveillance Research Program, Division of Cancer Control and Population Sciences), M. A. Smith, R. S. Kaplan (Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis), E. F. Heineman, M.S. Linet (Division of Cancer Etiology), National Cancer Institute, Bethesda, MD.
Correspondence to: Julie M. Legler, Sc.D., National Institutes of Health, Executive Plaza North, Suite 313, Bethesda, MD 20892-7344.
BACKGROUND: During the 1980s, the incidence of primary malignant brain and other central nervous system tumors (hereafter called brain cancer) was reported to be increasing among all age groups in the United States, while mortality was declining for persons younger than 65 years. We analyzed these data to provide updates on incidence and mortality trends for brain cancer in the United States and to examine these patterns in search of their causes. METHODS: Data on incidence, overall and according to histology and anatomic site, and on relative survival were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute for 1975 through 1995. Mortality data were obtained from the National Center for Health Statistics. Medicare procedure claims from the National Cancer Institute's SEER-Medicare database were used for imaging trends. Statistically significant changes in incidence trends were identified, and annual percent changes were computed for log linear models. RESULTS/CONCLUSIONS: Rates stabilized for all age groups during the most recent period for which SEER data were available, except for the group containing individuals 85 years of age or older. Mortality trends continued to decline for the younger age groups, and the steep increases in mortality seen in the past for the elderly slowed substantially. Patterns differed by age group according to the site and grade of tumors between younger and older patients. During the last decade, use of computed tomography scans was relatively stable for those 65-74 years old but increased among those 85 years old or older. IMPLICATIONS: Improvements in diagnosis and changes in the diagnosis and treatment of elderly patients provide likely explanations for the observed patterns in brain cancer trends.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. P. Reddy, R. Britto, K. Vinnakota, H. Aparna, H. K. Sreepathi, B. Thota, A. Kumari, B.M. Shilpa, M. Vrinda, S. Umesh, et al. Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis Clin. Cancer Res., May 15, 2008; 14(10): 2978 - 2987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Larjavaara, R. Mantyla, T. Salminen, H. Haapasalo, J. Raitanen, J. Jaaskelainen, and A. Auvinen Incidence of gliomas by anatomic location Neuro-oncol, July 1, 2007; 9(3): 319 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. French, J. Peeters, S. Horsman, E. Duijm, I. Siccama, M. J. van den Bent, T. M. Luider, J. M. Kros, P. van der Spek, and P. A. Sillevis Smitt Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays Cancer Res., June 15, 2007; 67(12): 5635 - 5642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Santra, X. Zhang, S. Santra, F. Jiang, and M. Chopp Ectopic Doublecortin Gene Expression Suppresses the Malignant Phenotype in Glioblastoma Cells Cancer Res., December 15, 2006; 66(24): 11726 - 11735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Li, C.-C. Tzeng, J. H. Song, F.-J. Tsia, L.-J. Hsieh, S.-J. Liao, C.-H. Tsai, E. G. Van Meir, C. Hao, and C.-C. Lin Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin. Cancer Res., May 1, 2006; 12(9): 2716 - 2729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Cher, C. Murone, N. Lawrentschuk, S. Ramdave, A. Papenfuss, A. Hannah, G. J. O'Keefe, J. I. Sachinidis, S. U. Berlangieri, G. Fabinyi, et al. Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Gliomas Using 18F-Fluoromisonidazole, 18F-FDG PET, and Immunohistochemical Studies J. Nucl. Med., March 1, 2006; 47(3): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hoffman, J. M. Propp, and B. J. McCarthy Temporal trends in incidence of primary brain tumors in the United States, 1985-1999 Neuro-oncol, January 1, 2006; 8(1): 27 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. French, S. M.A. Swagemakers, J. H.A. Nagel, M. C.M. Kouwenhoven, E. Brouwer, P. van der Spek, T. M. Luider, J. M. Kros, M. J. van den Bent, and P. A. Sillevis Smitt Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas Cancer Res., December 15, 2005; 65(24): 11335 - 11344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Cohen, E. A. Knopp, H. Rusinek, J. S. Babb, D. Zagzag, and O. Gonen Assessing Global Invasion of Newly Diagnosed Glial Tumors with Whole-Brain Proton MR Spectroscopy AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2170 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Rich, C. Hans, B. Jones, E. S. Iversen, R. E. McLendon, B.K. A. Rasheed, A. Dobra, H. K. Dressman, D. D. Bigner, J. R. Nevins, et al. Gene Expression Profiling and Genetic Markers in Glioblastoma Survival Cancer Res., May 15, 2005; 65(10): 4051 - 4058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Walker, D. G. du Plessis, D. Fildes, B. Haylock, D. Husband, M. D. Jenkinson, K. A. Joyce, J. Broome, K. Kopitski, J. Prosser, et al. Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component Clin. Cancer Res., November 1, 2004; 10(21): 7182 - 7191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fang, M. Kulldorff, and D. I. Gregorio Brain cancer mortality in the United States, 1986 to 1995: A geographic analysis Neuro-oncol, July 1, 2004; 6(3): 179 - 187. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Hegde, J. Roscoe, P. Cala, and F. Gorin Amiloride Kills Malignant Glioma Cells Independent of Its Inhibition of the Sodium-Hydrogen Exchanger J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 67 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Miller How Environmental Hazards in Childhood Have Been Discovered: Carcinogens, Teratogens, Neurotoxicants, and Others Pediatrics, April 1, 2004; 113(4/S1): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D Inskip, R. E Tarone, E. E Hatch, T. C Wilcosky, H. A Fine, P. M Black, J. S Loeffler, W. R Shapiro, R. G Selker, and M. S Linet Sociodemographic indicators and risk of brain tumours Int. J. Epidemiol., April 1, 2003; 32(2): 225 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger Epidemiology of primary brain tumors: Current concepts and review of the literature Neuro-oncol, October 1, 2002; 4(4): 278 - 299. [Abstract] [PDF]
|
|
|
|
|
|
S. Sinha, M. E. Bastin, I. R. Whittle, and J. M. Wardlaw Diffusion Tensor MR Imaging of High-Grade Cerebral Gliomas AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 520 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Choi, O. Kutsch, J. Park, T. Zhou, D.-W. Seol, and E. N. Benveniste Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Induces Caspase-Dependent Interleukin-8 Expression and Apoptosis in Human Astroglioma Cells Mol. Cell. Biol., February 1, 2002; 22(3): 724 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Osborne, M. P.W.A. Houben, C. C. Tijssen, J. W.W. Coebergh, and C. M. van Duijn The genetic epidemiology of glioma Neurology, November 27, 2001; 57(10): 1751 - 1755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Jukich, B. J. McCarthy, T. S. Surawicz, S. Freels, and F. G. Davis Trends in incidence of primary brain tumors in the United States, 1985-1994 Neuro-oncol, July 1, 2001; 3(3): 141 - 151. [Abstract] [PDF]
|
|
|
|
|
|
F. G. Davis, V. Kupelian, S. Freels, B. McCarthy, and T. Surawicz Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups Neuro-oncol, July 1, 2001; 3(3): 152 - 158. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Bobola, M. S. Berger, R. G. Ellenbogen, T. S. Roberts, J. R. Geyer, and J. R. Silber O6-Methylguanine-DNA Methyltransferase in Pediatric Primary Brain Tumors: Relation to Patient and Tumor Characteristics Clin. Cancer Res., March 1, 2001; 7(3): 613 - 619. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. L. Chenevert, L. D. Stegman, J. M. G. Taylor, P. L. Robertson, H. S. Greenberg, A. Rehemtulla, and B. D. Ross Diffusion Magnetic Resonance Imaging: an Early Surrogate Marker of Therapeutic Efficacy in Brain Tumors J Natl Cancer Inst, December 20, 2000; 92(24): 2029 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Muscat, M. G. Malkin, S. Thompson, R. E. Shore, S. D. Stellman, D. McRee, A. I. Neugut, and E. L. Wynder Handheld Cellular Telephone Use and Risk of Brain Cancer JAMA, December 20, 2000; 284(23): 3001 - 3007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Segal Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality J Natl Cancer Inst, January 5, 2000; 92(1): 77 - 77. [Full Text] [PDF]
|
|
|
|
|
|
C. B. Schechter Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality J Natl Cancer Inst, December 1, 1999; 91(23): 2050 - 2050. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Legler, L. A. Gloeckler Ries, M. A. Smith, J. L. Warren, E. F. Heineman, R. S. Kaplan, and M. S. Linet RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality J Natl Cancer Inst, December 1, 1999; 91(23): 2050a - 2051a. [Full Text] [PDF]
|
|